NSE: CORONA | BSE: 544644

Download real time

1443.50 41.10 (2.93%)

250.0K NSE+BSE Volume

NSE 02 Jan, 2026 3:31 PM (IST)

8,828.5

Market Cap

Above industry Median

Corona Remedies Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for CORONA, BSE:544644 Corona Remedies Ltd.

Search Inside the pdf :

Corona Remedies Ltd.

08 Dec 2025

1443.50

2.93%

IPO Note - Corona Remedies Limited - 08122025

IPO Note: Corona Remedies Ltd.

HDFC Securities

IPO Note - Corona Remedies Limited Corona Remedies Limited is an India-focused branded pharma firm, develops, manufactures, and markets 71 brands across women's healthcare, cardio-diabeto, pain management, urology, and more

Corona Remedies has gained 35.92% in the last 1 Month

Corona Remedies Ltd.

08 Dec 2025

1443.50

2.93%

CORONA REMEDIES LIMITED

IPO Subscribe: Corona Remedies Ltd.

Hem Securities

formulation company engaged in developing, manufacturing and marketing products in women's healthcare, cardio-diabeto, pain management, urology and other therapeutic areas. Company is the fastest growing company among the top 30 companies in the Indian Pharmaceutical Market (IPM) in terms of domestic sales in the IPM, between MAT June 2024 and MAT June 2025. During this period, company's domestic sales grew at a CAGR of 13.58% compared to the IPM which grew at a CAGR of...

Corona Remedies has gained 35.92% in the last 1 Month

Corona Remedies Ltd.

08 Dec 2025

1443.50

2.93%

IPO Note

IPO Subscribe: Corona Remedies Ltd.

Deven Choksey

The company has undertaken recent acquisitions like Myoril from Sanofi and Spye from Bayer. It is bolstering its gynaecology and cardiology portfolio and executed a partnership with Ferring for Solifenacin.

Corona Remedies has gained 35.92% in the last 3 Months

Corona Remedies Ltd.

05 Dec 2025, 12:00AM

1443.50

2.93%

CORONA REMEDIES LTD.

IPO Subscribe: Corona Remedies Ltd.

Ventura

IPO NOTE

Corona Remedies has gained 35.92% in the last 6 Months

Corona Remedies Ltd.

05 Dec 2025, 12:00AM

1443.50

2.93%

Corona Remedies: IPO

IPO Note: Corona Remedies Ltd.

ICICI Direct

The company owns installed capacity for wide range of dosage and packaging forms, such as tablets, capsules (including hard and soft gelatines), sachets, liquids and drops, with a total of 11 production lines...

Corona Remedies has gained 35.92% in the last 6 Months

Corona Remedies Ltd.

04 Dec 2025

1443.50

2.93%

Corona Remedies Ltd IPO Note

IPO Subscribe: Corona Remedies Ltd.

SBI Securities

Corona Remedies Ltd (Corona) is an India-focused domestic branded formulations company engaged in the development, manufacturing & marketing of products in the women's health, cardio-diabeto, pain management, urology, etc therapies. The company's diversified product portfolio comprises of 71 brands, including 27 engine brands as of Jun'25. On MAT Jun'25 basis, Corona was the 29th largest pharmaceutical company in India and positioned as the 17th largest company in its covered...